A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system

29Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is an increasing demand for easy, high-throughput (HTP) methods for protein engineering to support advances in the development of structural biology, bioinformatics and drug design. Here, we describe an N- and C-terminal cloning method utilizing Gateway cloning technology that we have adopted for chimeric and mutant genes production as well as domain shuffling. This method involves only three steps: PCR, in vitro recombination and transformation. All three processes consist of simple handling, mixing and incubation steps. We have characterized this novel HTP method on 96 targets with >90% success. Here, we also discuss an N- and C-terminal cloning method for domain shuffling and a combination of mutation and chimeragenesis with two types of plasmid vectors. © The Author 2005. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Suzuki, Y., Kagawa, N., Fujino, T., Sumiya, T., Andoh, T., Ishikawa, K., … Tanaka, S. (2005). A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system. Nucleic Acids Research, 33(12), 1–6. https://doi.org/10.1093/nar/gni103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free